$PAYX
PAYCHEX INC Stock $payx

$payx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000095017023032988 Filed on July 14, 2023

Income Statement

Concept	2023 Q2	2023
Revenue	$1.230B	$5.007B
YoY Change	7.45%	8.57%
Cost Of Revenue		$1.453B
YoY Change		7.13%
Gross Profit		$3.554B
YoY Change		9.18%
Gross Profit Margin		70.98%
Selling, General & Admin	$459.5M	$1.783B
YoY Change	4.38%	25.94%
% of Gross Profit		50.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$44.10M	$176.6M
YoY Change	-10.18%	-7.92%
% of Gross Profit		4.97%
Operating Expenses	$776.3M	$2.974B
YoY Change	3.47%	110.12%
Operating Profit		$2.033B
YoY Change		10.49%
Interest Expense	-$500.0K	$2.600M
YoY Change	-93.06%	-92.9%
% of Operating Profit		0.13%
Other Income/Expense, Net	$10.80M	$12.50M
YoY Change	440.0%	-31.69%
Pretax Income	$463.6M	$2.048B
YoY Change	19.24%	12.25%
Income Tax	$113.2M	$490.9M
% Of Pretax Income	24.42%	23.97%
Net Earnings	$350.4M	$1.557B
YoY Change	18.22%	11.81%
Net Earnings / Revenue	28.5%	31.1%
Basic Earnings Per Share		$4.32
Diluted Earnings Per Share	$0.97	$4.30
COMMON SHARES
Basic Shares Outstanding	360.5M	360.4M
Diluted Shares Outstanding		362.3M

Balance Sheet

Concept	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.595B	$1.595B
YoY Change	30.35%	30.35%
Cash & Equivalents	$1.222B	$1.222B
Short-Term Investments	$373.4M	$373.4M
Other Short-Term Assets	$4.507B	$4.507B
YoY Change	11.56%	11.56%
Inventory
Prepaid Expenses
Receivables	$1.402B	$1.402B
Other Receivables	$24.40M	$24.40M
Total Short-Term Assets	$7.528B	$7.528B
YoY Change	14.38%	14.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$457.8M	$457.8M
YoY Change	14.08%	-4.63%
Goodwill	$1.834B
YoY Change	0.14%
Intangibles	$187.4M
YoY Change	-16.56%
Long-Term Investments	$3.800M	$3.800M
YoY Change	-24.0%	-24.0%
Other Assets	$535.3M	$535.3M
YoY Change	896.83%	4.45%
Total Long-Term Assets	$3.018B	$3.018B
YoY Change	-1.16%	-1.16%
TOTAL ASSETS
Total Short-Term Assets	$7.528B	$7.528B
Total Long-Term Assets	$3.018B	$3.018B
Total Assets	$10.55B	$10.55B
YoY Change	9.46%	9.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$84.70M	$84.70M
YoY Change	-19.87%	-19.87%
Accrued Expenses	$973.8M	$994.1M
YoY Change	4.27%	6.45%
Deferred Revenue	$47.30M
YoY Change	23.18%
Short-Term Debt	$10.20M	$10.20M
YoY Change	17.24%	17.24%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.805B	$5.805B
YoY Change	10.18%	10.18%
LONG-TERM LIABILITIES
Long-Term Debt	$798.2M	$798.2M
YoY Change	0.06%	0.06%
Other Long-Term Liabilities	$337.5M	$337.5M
YoY Change	82.73%	6.27%
Total Long-Term Liabilities	$1.136B	$1.136B
YoY Change	15.6%	1.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.805B	$5.805B
Total Long-Term Liabilities	$1.136B	$1.136B
Total Liabilities	$7.053B	$7.053B
YoY Change	7.68%	7.68%
SHAREHOLDERS EQUITY
Retained Earnings	$2.023B
YoY Change	21.17%
Common Stock	$1.630B
YoY Change	5.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.493B	$3.493B
YoY Change
Total Liabilities & Shareholders Equity	$10.55B	$10.55B
YoY Change	9.46%	9.46%

Cashflow Statement

Concept	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	$350.4M	$1.557B
YoY Change	18.22%	11.81%
Depreciation, Depletion And Amortization	$44.10M	$176.6M
YoY Change	-10.18%	-7.92%
Cash From Operating Activities	$409.3M	$1.699B
YoY Change	21.38%	12.88%
INVESTING ACTIVITIES
Capital Expenditures	$44.80M	$153.4M
YoY Change	-233.33%	15.69%
Acquisitions		$2.700M
YoY Change		-89.16%
Other Investing Activities	-$99.10M	$371.9M
YoY Change	-54.79%	-129.11%
Cash From Investing Activities	-$143.9M	$218.5M
YoY Change	-43.08%	-115.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-492.9M	-711.4M
YoY Change	-47.89%	-27.36%
NET CHANGE
Cash From Operating Activities	409.3M	1.699B
Cash From Investing Activities	-143.9M	218.5M
Cash From Financing Activities	-492.9M	-711.4M
Net Change In Cash	-227.5M	1.207B
YoY Change	-73.59%	-234.85%
FREE CASH FLOW
Cash From Operating Activities	$409.3M	$1.699B
Capital Expenditures	$44.80M	$153.4M
Free Cash Flow	$364.5M	$1.546B
YoY Change	-1.7%	12.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000723531
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-05-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-11330
CY2023	dei	Entity Registrant Name EntityRegistrantName	Paychex, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1124166
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	911 Panorama Trail South
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Rochester
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14625-2396
CY2023	dei	City Area Code CityAreaCode	585
CY2023	dei	Local Phone Number LocalPhoneNumber	385-6666
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	PAYX
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	31621134084
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	360545780
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Rochester, New York
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4907300000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4554000000.0
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3997500000
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	99800000
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	57700000
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	59300000
CY2023	us-gaap	Revenues Revenues	5007100000
CY2022	us-gaap	Revenues Revenues	4611700000
CY2021	us-gaap	Revenues Revenues	4056800000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1453000000.0
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1356300000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1271200000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1521000000.0
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1415400000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1324900000
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	2974000000.0
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2771700000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2596100000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2033100000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1840000000.0
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1460700000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	15100000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-15400000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-26500000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2048200000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1824600000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1434200000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	490900000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431800000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	336700000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1557300000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1392800000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1097500000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-26000000.0
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-185700000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4700000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1531300000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1207100000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1092800000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.86
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.30
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.03
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	360400000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	360600000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	359900000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	362300000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	363100000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	362100000
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1222000000.0
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	8700000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	370000000.0
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	49800000
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	50300000
CY2023Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	373400000
CY2022Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	853900000
CY2023Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	24400000
CY2022Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	22300000
CY2023Q2	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	873300000
CY2022Q2	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	723800000
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	528500000
CY2022Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	572100000
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	48100000
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	34000000.0
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	289800000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272300000
CY2023Q2	payx	Current Assets Before Funds Held For Clients CurrentAssetsBeforeFundsHeldForClients	3409300000
CY2022Q2	payx	Current Assets Before Funds Held For Clients CurrentAssetsBeforeFundsHeldForClients	2898700000
CY2023Q2	us-gaap	Funds Held For Clients FundsHeldForClients	4118800000
CY2022Q2	us-gaap	Funds Held For Clients FundsHeldForClients	3682900000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	7528100000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	6581600000
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	25500000
CY2023Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossNoncurrent	3800000
CY2022Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossNoncurrent	5000000.0
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	396300000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	401300000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61500000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	78700000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	187400000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	224600000
CY2023Q2	us-gaap	Goodwill Goodwill	1834000000.0
CY2022Q2	us-gaap	Goodwill Goodwill	1831500000
CY2023Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	470100000
CY2022Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	433300000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	65200000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53700000
CY2023Q2	us-gaap	Assets Assets	10546400000
CY2022Q2	us-gaap	Assets Assets	9635200000
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	84700000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	105700000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	209900000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	225400000
CY2023Q2	payx	Accrued Worksite Employee Compensation And Related Items AccruedWorksiteEmployeeCompensationAndRelatedItems	763900000
CY2022Q2	payx	Accrued Worksite Employee Compensation And Related Items AccruedWorksiteEmployeeCompensationAndRelatedItems	683400000
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	10200000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-14700000
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	300000
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	900000
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.52
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	908700000
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	47300000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	38400000
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	395400000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	388400000
CY2023Q2	payx	Current Liabilities Before Client Fund Obligations CurrentLiabilitiesBeforeClientFundObligations	1511400000
CY2022Q2	payx	Current Liabilities Before Client Fund Obligations CurrentLiabilitiesBeforeClientFundObligations	1450000000.0
CY2023Q2	payx	Client Fund Obligations ClientFundObligations	4294000000.0
CY2022Q2	payx	Client Fund Obligations ClientFundObligations	3819200000
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5805400000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5269200000
CY2023Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	83000000.0
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	58100000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	112100000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	165500000
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	798200000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	797700000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57300000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74800000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	197200000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	184700000
CY2023Q2	us-gaap	Liabilities Liabilities	7053200000
CY2022Q2	us-gaap	Liabilities Liabilities	6550000000.0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000.0
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000.0
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	360500000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	360500000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	359900000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	359900000
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3600000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	3600000
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1626400000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1545900000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2023100000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1669600000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-159900000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-133900000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3493200000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3085200000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10546400000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9635200000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2781400000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1097500000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-4800000
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	155700000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52500000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10900000
CY2021	payx	Stock Issued During Period Value Share Based Compensation1 StockIssuedDuringPeriodValueShareBasedCompensation1	85700000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2948000000.0
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1392800000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-53100000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-162300000
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	100000
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	100000
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.77
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	1000100000
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	145200000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52800000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23300000
CY2022	payx	Stock Issued During Period Value Share Based Compensation1 StockIssuedDuringPeriodValueShareBasedCompensation1	22600000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3085200000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1557300000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-12200000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-36600000
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	-2500000
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-7400000
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.26
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	1175500000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	62600000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3200000
CY2023	payx	Stock Issued During Period Value Share Based Compensation1 StockIssuedDuringPeriodValueShareBasedCompensation1	-10400000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3493200000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1557300000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1392800000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1097500000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	176600000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191800000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	192000000.0
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-18200000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-28900000
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-35800000
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	219100000
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	202100000
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	191400000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	62600000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	52800000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	52500000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-44000000.0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2300000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21000000.0
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	17700000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10500000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8000000.0
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-9800000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	200000
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	1200000
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2100000
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2100000
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1800000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	123600000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	277000000.0
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	272900000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17800000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7700000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15800000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	67400000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	151800000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	169000000.0
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	269400000
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	267100000
CY2021	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	208000000.0
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-31900000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-26300000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-32100000
CY2023	payx	Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet	4300000
CY2022	payx	Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet	3900000
CY2021	payx	Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet	900000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1699400000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1505500000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1260300000
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	14585300000
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	17807700000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	6089700000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	14943200000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	16554900000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5771900000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	143000000.0
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133800000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118400000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16700000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1200000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3800000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2700000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	24900000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	19500000
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	10400000
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	10600000
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	8700000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	218500000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1420900000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-460600000
CY2023	payx	Net Change In Client Fund Obligations NetChangeInClientFundObligations	474800000
CY2022	payx	Net Change In Client Fund Obligations NetChangeInClientFundObligations	143200000
CY2021	payx	Net Change In Client Fund Obligations NetChangeInClientFundObligations	340000000.0
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2000000.0
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1300000
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2300000
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1175000000.0
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	999600000
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	908700000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	145200000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	155700000
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2800000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1600000
CY2023	payx	Equity Activity Related To Stock Based Awards EquityActivityRelatedToStockBasedAwards	-10400000
CY2022	payx	Equity Activity Related To Stock Based Awards EquityActivityRelatedToStockBasedAwards	22600000
CY2021	payx	Equity Activity Related To Stock Based Awards EquityActivityRelatedToStockBasedAwards	85700000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-711400000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-979300000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-636400000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1206500000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-894700000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	163300000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	928400000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1823100000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1659800000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2134900000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	928400000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1823100000
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1222000000.0
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	370000000.0
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	995200000
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	49800000
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	75800000
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	88300000
CY2023Q2	payx	Restricted Cash And Restricted Cash Equivalents Included In Funds Held For Clients RestrictedCashAndRestrictedCashEquivalentsIncludedInFundsHeldForClients	863100000
CY2022Q2	payx	Restricted Cash And Restricted Cash Equivalents Included In Funds Held For Clients RestrictedCashAndRestrictedCashEquivalentsIncludedInFundsHeldForClients	482600000
CY2021Q2	payx	Restricted Cash And Restricted Cash Equivalents Included In Funds Held For Clients RestrictedCashAndRestrictedCashEquivalentsIncludedInFundsHeldForClients	739600000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2134900000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	928400000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1823100000
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Description of business:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> Paychex, Inc. and its wholly owned subsidiaries (collectively, the “Company” or “Paychex”) is a leading provider of integrated human capital management (“HCM”) solutions for human resources (“HR”), payroll, benefits, and insurance for small- to medium-sized businesses in the United States (“U.S.”) and parts of Europe. The Company also has operations in India.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Paychex, a Delaware corporation formed i</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n 1979, reports as </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> segment. Substantially all of the Company’s revenue is generated within the U.S. Approximately </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> percent of the Company’s total revenue was generated within Europe for each of the fiscal years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">May 31, 2023 (“fiscal 2023”), May 31, 2022 (“fiscal 2022”), and May 31, 2021 (“fiscal 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">”). Long-lived assets in Europe were approximately </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of total long-lived assets of the Company as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">May 31, 2023 and 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. Long-lived assets in India were less than </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of total long-lived assets of the Company as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">May 31, 2023 and 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Within Paychex’s HCM solutions, the Company offers a comprehensive portfolio of HCM technology and HR advisory solutions that help our clients address the evolving challenges of HR. Clients may choose to have our support teams handle everything for them, or select services on an á la carte basis or as part of various solution bundles. Paychex’s offerings often leverage the information gathered in its base payroll processing service, allowing the Company to provide comprehensive outsourcing services covering the HCM spectrum.</span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Paychex supports its small business clients utilizing its proprietary, robust, software as a service (“SaaS”) Paychex Flex</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:"Times New Roman", serif;min-width:fit-content;">®</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> platform and the Company’s SurePayroll</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:"Times New Roman", serif;min-width:fit-content;">®</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> SaaS-based solutions. Both solutions allow users to process payroll when they want, how they want, and on any type of device (desktop, tablet, and mobile phone). Paychex’s medium-sized clients generally have more complex payroll and employee benefit needs and can opt for an integrated suite of HCM solutions, which allows them to choose the services and software that will meet the needs of their businesses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Total revenue is comprised of service revenue and interest on funds held for clients. Service revenue is comprised primarily of the fees earned on the portfolio of HCM services, which include payroll processing, complementary HR management and administration services, professional employer organization (“PEO”) solutions, and insurance agency commissions. Refer to Note B of this Item 8 for further discussion of the Company’s service revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Reclassifications:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported consolidated earnings.</span></p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20500000
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18200000
CY2023Q2	payx	Advance Collections Current AdvanceCollectionsCurrent	12500000
CY2022Q2	payx	Advance Collections Current AdvanceCollectionsCurrent	2600000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Concentrations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> Substantially all the Company’s deposited cash is maintained at large well-capitalized (as defined by their regulators) financial institutions. These deposits may exceed the amount of any insurance provided. All the Company’s deliverable securities, primarily municipal bond securities, are held in custody with certain of the aforementioned financial institutions, for which that institution bears the risk of custodial loss. Non-deliverable securities are primarily time deposits and money market funds.</span></p>
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0
CY2022	payx	Direct Pass Through Cost Payroll Wages And Taxes Including Federal And State Unemployment Insurance DirectPassThroughCostPayrollWagesAndTaxesIncludingFederalAndStateUnemploymentInsurance	24209300000
CY2021	payx	Direct Pass Through Cost Payroll Wages And Taxes Including Federal And State Unemployment Insurance DirectPassThroughCostPayrollWagesAndTaxesIncludingFederalAndStateUnemploymentInsurance	20706100000
CY2023	payx	Direct Pass Through Cost State Unemployment Insurance DirectPassThroughCostStateUnemploymentInsurance	138200000
CY2022	payx	Direct Pass Through Cost State Unemployment Insurance DirectPassThroughCostStateUnemploymentInsurance	139100000
CY2023	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2022	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2021	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2023Q2	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	64300000
CY2022Q2	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	64100000
CY2023Q2	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	131500000
CY2022Q2	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	125600000
CY2023	payx	Maximum Individual Claims Liability Health Insurance MaximumIndividualClaimsLiabilityHealthInsurance	500000
CY2022	payx	Maximum Individual Claims Liability Health Insurance MaximumIndividualClaimsLiabilityHealthInsurance	500000
CY2023Q2	payx	Peo Health Insurance Dental And Vision Plan Costs Current Liabilities PeoHealthInsuranceDentalAndVisionPlanCostsCurrentLiabilities	47000000.0
CY2022Q2	payx	Peo Health Insurance Dental And Vision Plan Costs Current Liabilities PeoHealthInsuranceDentalAndVisionPlanCostsCurrentLiabilities	46200000
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0
CY2021	payx	Direct Pass Through Cost State Unemployment Insurance DirectPassThroughCostStateUnemploymentInsurance	119000000.0
CY2023	payx	Direct Pass Through Cost Guaranteed Cost Benefit Plans DirectPassThroughCostGuaranteedCostBenefitPlans	656300000
CY2022	payx	Direct Pass Through Cost Guaranteed Cost Benefit Plans DirectPassThroughCostGuaranteedCostBenefitPlans	641400000
CY2021	payx	Direct Pass Through Cost Guaranteed Cost Benefit Plans DirectPassThroughCostGuaranteedCostBenefitPlans	586400000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of estimates:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments, and assumptions that affect reported amounts of assets, liabilities, revenue, and expenses during the reporting period. Actual amounts and results could differ from these estimates.</span></p>
CY2023	payx	Customer Contract Termination Notice Days CustomerContractTerminationNoticeDays	P30D
CY2023	payx	Direct Pass Through Cost Payroll Wages And Taxes Including Federal And State Unemployment Insurance DirectPassThroughCostPayrollWagesAndTaxesIncludingFederalAndStateUnemploymentInsurance	26025300000
CY2023	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	the Company defers revenue associated with these performance obligations, which exceed one year, and subsequently recognizes them as future services are provided, over approximately three years to four years.
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	48900000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	40200000
CY2023	payx	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	42100000
CY2022	payx	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	35000000.0
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	29000000.0
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	26300000
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	62000000.0
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	48900000
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	26600000
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	35400000
CY2023	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2022	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2021	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1557300000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1392800000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1097500000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	360400000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	360600000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	359900000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.86
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.05
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1557300000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1392800000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1097500000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	360400000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	360600000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	359900000
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1900000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2500000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2200000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	362300000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	363100000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	362100000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.30
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.03
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	49100000
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2900000
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2300000
CY2023	us-gaap	Interest Expense InterestExpense	36700000
CY2022	us-gaap	Interest Expense InterestExpense	36600000
CY2021	us-gaap	Interest Expense InterestExpense	35800000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18300000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000.0
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	15100000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-15400000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-26500000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	46500000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	14200000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62600000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52800000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52500000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12100000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	9800000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8600000
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	97500000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2023Q2	payx	Funds Held For Clients Money Market Securities And Other Cash Equivalents Amortized Cost FundsHeldForClientsMoneyMarketSecuritiesAndOtherCashEquivalentsAmortizedCost	863100000
CY2023Q2	payx	Funds Held For Clients Money Market Securities And Other Cash Equivalents Fair Value FundsHeldForClientsMoneyMarketSecuritiesAndOtherCashEquivalentsFairValue	863100000
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3779900000
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4100000
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	179400000
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3604600000
CY2023Q2	payx	Other Securities Amortized Cost OtherSecuritiesAmortizedCost	30100000
CY2023Q2	payx	Other Securities Gross Unrealized Gains OtherSecuritiesGrossUnrealizedGains	1100000
CY2023Q2	payx	Other Securities Gross Unrealized Losses OtherSecuritiesGrossUnrealizedLosses	2900000
CY2023Q2	payx	Other Securities Fair Value OtherSecuritiesFairValue	28300000
CY2023Q2	payx	Funds Held For Clients And Corporate Investments Amortized Cost FundsHeldForClientsAndCorporateInvestmentsAmortizedCost	4673100000
CY2023Q2	payx	Funds Held For Clients And Corporate Investments Gross Unrealized Gains FundsHeldForClientsAndCorporateInvestmentsGrossUnrealizedGains	5200000
CY2023Q2	payx	Funds Held For Clients And Corporate Investments Gross Unrealized Losses FundsHeldForClientsAndCorporateInvestmentsGrossUnrealizedLosses	182300000
CY2023Q2	payx	Funds Held For Clients And Corporate Investments Fair Value FundsHeldForClientsAndCorporateInvestmentsFairValue	4496000000.0
CY2022Q2	payx	Funds Held For Clients Money Market Securities And Other Cash Equivalents Amortized Cost FundsHeldForClientsMoneyMarketSecuritiesAndOtherCashEquivalentsAmortizedCost	482600000
CY2022Q2	payx	Funds Held For Clients Money Market Securities And Other Cash Equivalents Fair Value FundsHeldForClientsMoneyMarketSecuritiesAndOtherCashEquivalentsFairValue	482600000
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4165500000
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2700000
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	139000000.0
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4029200000
CY2022Q2	payx	Other Securities Amortized Cost OtherSecuritiesAmortizedCost	30400000
CY2022Q2	payx	Other Securities Gross Unrealized Gains OtherSecuritiesGrossUnrealizedGains	1800000
CY2022Q2	payx	Other Securities Gross Unrealized Losses OtherSecuritiesGrossUnrealizedLosses	2200000
CY2022Q2	payx	Other Securities Fair Value OtherSecuritiesFairValue	30000000.0
CY2022Q2	payx	Funds Held For Clients And Corporate Investments Amortized Cost FundsHeldForClientsAndCorporateInvestmentsAmortizedCost	4678500000
CY2022Q2	payx	Funds Held For Clients And Corporate Investments Gross Unrealized Gains FundsHeldForClientsAndCorporateInvestmentsGrossUnrealizedGains	4500000
CY2022Q2	payx	Funds Held For Clients And Corporate Investments Gross Unrealized Losses FundsHeldForClientsAndCorporateInvestmentsGrossUnrealizedLosses	141200000
CY2022Q2	payx	Funds Held For Clients And Corporate Investments Fair Value FundsHeldForClientsAndCorporateInvestmentsFairValue	4541800000
CY2023Q2	us-gaap	Funds Held For Clients FundsHeldForClients	4118800000
CY2022Q2	us-gaap	Funds Held For Clients FundsHeldForClients	3682900000
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	373400000
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	853900000
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	3800000
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	5000000.0
CY2023Q2	payx	Funds Held For Clients And Corporate Investments Fair Value FundsHeldForClientsAndCorporateInvestmentsFairValue	4496000000.0
CY2022Q2	payx	Funds Held For Clients And Corporate Investments Fair Value FundsHeldForClientsAndCorporateInvestmentsFairValue	4541800000
CY2023	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	175300000
CY2022	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	136300000
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	967
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	817
CY2023Q2	payx	Available For Sale Securities In Unrealized Loss Positions Percentage AvailableForSaleSecuritiesInUnrealizedLossPositionsPercentage	0.88
CY2022Q2	payx	Available For Sale Securities In Unrealized Loss Positions Percentage AvailableForSaleSecuritiesInUnrealizedLossPositionsPercentage	0.64
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	15200000
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	992500000
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	164200000
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1752900000
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	179400000
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	2745400000
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	116200000
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2059600000
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	22800000
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	200700000
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	139000000.0
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	2260300000
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	179400000
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	100000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	200000
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	1200000
CY2023	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	9900000
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-0.0
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-9800000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	200000
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	1200000
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	186400000
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	184100000
CY2023Q2	payx	Available For Sale Securities Debt Maturities After Year One Through Year Three Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesAfterYearOneThroughYearThreeAmortizedCostBasis	829400000
CY2023Q2	payx	Available For Sale Securities Debt Maturities After Year One Through Year Three Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterYearOneThroughYearThreeFairValue	789600000
CY2023Q2	payx	Available For Sale Securities Debt Maturities After Year Three Through Year Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesAfterYearThreeThroughYearFiveAmortizedCostBasis	1953700000
CY2023Q2	payx	Available For Sale Securities Debt Maturities After Year Three Through Year Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterYearThreeThroughYearFiveFairValue	1843500000
CY2023Q2	payx	Available For Sale Securities Debt Maturities After Five Years Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCostBasis	810400000
CY2023Q2	payx	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	787400000
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3779900000
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3604600000
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	43800000
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3604600000
CY2023Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	28300000
CY2023Q2	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	28300000
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	219200000
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4029200000
CY2022Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	30000000.0
CY2022Q2	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	29900000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61500000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	78700000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20300000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25100000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57300000
CY2021	payx	Lease Incentives Received LeaseIncentivesReceived	800000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74800000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0221
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0194
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	20800000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	27200000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	34600000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	6200000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	6900000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	8300000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0.0
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	100000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	24400000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	21700000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	32400000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	32200000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	17600000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	22700000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	29200000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1300000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15800000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	26800000
CY2023	payx	Lease Incentives Received LeaseIncentivesReceived	800000
CY2022	payx	Lease Incentives Received LeaseIncentivesReceived	9100000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	45000000.0
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	21800000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	19500000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13600000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9900000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	7800000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	9100000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	81700000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4100000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	77600000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20300000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57300000
CY2023Q2	payx	Lessee Operating Number Of Leases Not Yet Commenced LesseeOperatingNumberOfLeasesNotYetCommenced	1
CY2023Q2	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P5Y
CY2023Q2	payx	Lessee Operating Lease Liability Payments Not Yet Commenced LesseeOperatingLeaseLiabilityPaymentsNotYetCommenced	1300000
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1477500000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1457000000.0
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1081200000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1055700000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	396300000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	401300000
CY2023	us-gaap	Depreciation Depreciation	128400000
CY2022	us-gaap	Depreciation Depreciation	133700000
CY2021	us-gaap	Depreciation Depreciation	123400000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	39800000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	35600000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	29300000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	26200000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	52400000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	56800000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	17300000
CY2022Q2	us-gaap	Goodwill Goodwill	1831500000
CY2021Q2	us-gaap	Goodwill Goodwill	1820700000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2500000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	27700000
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-0.0
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-16900000
CY2023Q2	us-gaap	Goodwill Goodwill	1834000000.0
CY2022Q2	us-gaap	Goodwill Goodwill	1831500000
CY2023Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	661200000
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	660400000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	473800000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	435800000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	187400000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	224600000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48200000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	58100000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	68600000
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	21300000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	200000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	200000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	14800000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12900000
CY2023Q2	us-gaap	Deferred Tax Assets Other Comprehensive Loss DeferredTaxAssetsOtherComprehensiveLoss	43400000
CY2022Q2	us-gaap	Deferred Tax Assets Other Comprehensive Loss DeferredTaxAssetsOtherComprehensiveLoss	33600000
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	54100000
CY2023Q2	payx	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	15900000
CY2022Q2	payx	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	20500000
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5100000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5600000
CY2023Q2	payx	Deferred Tax Assets Tax Benefit Of Uncertain Tax Positions DeferredTaxAssetsTaxBenefitOfUncertainTaxPositions	13600000
CY2022Q2	payx	Deferred Tax Assets Tax Benefit Of Uncertain Tax Positions DeferredTaxAssetsTaxBenefitOfUncertainTaxPositions	9900000
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	216800000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	160800000
CY2023Q2	payx	Deferred Tax Liabilities Deferred Expense Contract Costs DeferredTaxLiabilitiesDeferredExpenseContractCosts	151300000
CY2022Q2	payx	Deferred Tax Liabilities Deferred Expense Contract Costs DeferredTaxLiabilitiesDeferredExpenseContractCosts	141900000
CY2023Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	56500000
CY2022Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	50800000
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2400000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8100000
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	99100000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	103500000
CY2023Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	13700000
CY2022Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	17700000
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5700000
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4300000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	328700000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	326300000
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	111900000
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	165500000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	418100000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	326000000.0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	271500000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	117100000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	104500000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	85900000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-300000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-1000000.0
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	300000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	534900000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	429500000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	357700000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-34200000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	900000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12900000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-7400000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	900000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-7600000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2400000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	500000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-500000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-44000000.0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2300000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21000000.0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	490900000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431800000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	336700000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.046
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.043
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.003
CY2023	payx	Effective Income Tax Rate Reconciliation Stock Option Windfall Benefit EffectiveIncomeTaxRateReconciliationStockOptionWindfallBenefit	0.004
CY2022	payx	Effective Income Tax Rate Reconciliation Stock Option Windfall Benefit EffectiveIncomeTaxRateReconciliationStockOptionWindfallBenefit	0.009
CY2021	payx	Effective Income Tax Rate Reconciliation Stock Option Windfall Benefit EffectiveIncomeTaxRateReconciliationStockOptionWindfallBenefit	0.012
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.006
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.240
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.237
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2023Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	69400000
CY2022Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	48200000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	50200000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22400000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	26200000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	20600000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	11100000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5500000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4600000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	20600000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	9200000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2100000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1800000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	400000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	400000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	15200000
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	900000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1700000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3300000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	72000000.0
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	50200000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22400000
CY2023Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	69400000
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	69400000
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	48200000
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	800000000.0
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	800000000.0
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1800000
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2300000
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	798200000
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	797700000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	525800000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	397700000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	421400000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	35700000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	35500000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	34900000
CY2023Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	424700000
CY2023Q2	us-gaap	Contractual Obligation ContractualObligation	11800000

Files In Submission

Name	View Source	Status
0000950170-23-032988-index-headers.html	Edgar Link	pending
0000950170-23-032988-index.html	Edgar Link	pending
0000950170-23-032988.txt	Edgar Link	pending
0000950170-23-032988-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img59573503_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
payx-20230531.htm	Edgar Link	pending
payx-20230531.xsd	Edgar Link	pending
payx-ex21_1.htm	Edgar Link	pending
payx-ex23_1.htm	Edgar Link	pending
payx-ex24_1.htm	Edgar Link	pending
payx-ex31_1.htm	Edgar Link	pending
payx-ex31_2.htm	Edgar Link	pending
payx-ex32_1.htm	Edgar Link	pending
payx-ex32_2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
payx-20230531_def.xml	Edgar Link	unprocessable
payx-20230531_cal.xml	Edgar Link	unprocessable
payx-20230531_lab.xml	Edgar Link	unprocessable
payx-20230531_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
payx-20230531_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PAYX
PAYCHEX INC Stock $payx

2023 Q2 Form 10-K Financial Statement

#000095017023032988 Filed on July 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAYX PAYCHEX INC Stock $payx

2023 Q2 Form 10-K Financial Statement

#000095017023032988 Filed on July 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAYX
PAYCHEX INC Stock $payx